Waters Corporation $WAT Shares Acquired by KLP Kapitalforvaltning AS

Key Points

• KLP Kapitalforvaltning AS increased its stake in Waters Corporation by 11.8%, owning a total of 22,692 shares valued at approximately $7.92 million.
• The company reported a quarterly earnings per share (EPS) of $2.95, surpassing analysts' expectations of $2.93, and a revenue of $771.33 million, which is an 8.8% year-over-year increase.
• Waters stock currently holds a market capitalization of $19.67 billion and has a consensus price target of $377.56 from various analysts.

KLP Kapitalforvaltning AS lifted its stake in shares of Waters Corporation (NYSE:WAT - Free Report) by 11.8% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 22,692 shares of the medical instruments supplier's stock after buying an additional 2,400 shares during the quarter. KLP Kapitalforvaltning AS's holdings in Waters were worth $7,920,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also made changes to their positions in the company. Olde Wealth Management LLC acquired a new stake in shares of Waters during the first quarter worth approximately $25,000. Zions Bancorporation National Association UT acquired a new stake in shares of Waters during the first quarter worth approximately $28,000. IFP Advisors Inc grew its position in shares of Waters by 118.9% during the first quarter. IFP Advisors Inc now owns 81 shares of the medical instruments supplier's stock worth $30,000 after buying an additional 44 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new stake in shares of Waters during the first quarter worth approximately $41,000. Finally, CX Institutional acquired a new stake in shares of Waters during the first quarter worth approximately $75,000. Institutional investors and hedge funds own 94.01% of the company's stock.

Waters Stock Performance

WAT stock opened at $330.48 on Friday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.22 and a current ratio of 1.75. The stock has a market capitalization of $19.67 billion, a price-to-earnings ratio of 29.80, a PEG ratio of 3.05 and a beta of 1.04. Waters Corporation has a 1 year low of $275.05 and a 1 year high of $423.56. The stock's fifty day moving average is $299.15 and its two-hundred day moving average is $324.44.

Waters (NYSE:WAT - Get Free Report) last issued its quarterly earnings data on Monday, August 4th. The medical instruments supplier reported $2.95 earnings per share for the quarter, beating analysts' consensus estimates of $2.93 by $0.02. Waters had a net margin of 21.71% and a return on equity of 38.60%. The business had revenue of $771.33 million for the quarter, compared to analysts' expectations of $745.96 million. During the same period in the previous year, the business earned $2.63 earnings per share. The company's revenue was up 8.8% on a year-over-year basis. Waters has set its Q3 2025 guidance at 3.150-3.250 EPS. FY 2025 guidance at 12.950-13.050 EPS. On average, research analysts predict that Waters Corporation will post 12.86 EPS for the current year.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on WAT. UBS Group restated a "neutral" rating on shares of Waters in a research note on Tuesday, July 15th. Scotiabank restated a "sector outperform" rating and set a $465.00 price objective on shares of Waters in a research note on Friday, July 11th. Wells Fargo & Company reduced their price objective on Waters from $330.00 to $315.00 and set an "equal weight" rating on the stock in a research note on Tuesday, August 5th. Redburn Partners set a $390.00 price objective on Waters in a research note on Wednesday. Finally, Deutsche Bank Aktiengesellschaft set a $315.00 price objective on Waters and gave the stock a "hold" rating in a research note on Tuesday, August 5th. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $377.56.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.

Want to see what other hedge funds are holding WAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Waters Corporation (NYSE:WAT - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.